Achiziție pe piața medicamentelor: Dr.Max preia 18 farmacii Marcos Provit (Evofarm) - StartupCafe

The Competition Council has approved Dr.Max's acquisition of 18 Marcos Provit pharmacies, enhancing its retail presence in Romania. Dr.Max, part of Penta Investments, operates in pharmaceuticals and para-pharmaceuticals. The acquired pharmacies are located in several counties, and the Council found no significant competition concerns regarding the transaction. Marcos Provit, which operates the Evofarm brand, has a history of expansion, including recent acquisitions. In 2024, Marcos Provit reported a revenue of 317.1 million lei but also faced a loss of 18.9 million lei.